Stephens Investment Management Group LLC raised its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 34.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 976,998 shares of the company's stock after purchasing an additional 247,918 shares during the period. Stephens Investment Management Group LLC owned approximately 1.18% of HealthEquity worth $86,425,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of HQY. Silvant Capital Management LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at $35,000. Axiom Investment Management LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at $33,000. Public Employees Retirement System of Ohio acquired a new stake in HealthEquity during the 2nd quarter worth $39,000. Jacobi Capital Management LLC acquired a new stake in HealthEquity during the 3rd quarter worth $48,000. Finally, IFP Advisors Inc lifted its holdings in HealthEquity by 387.3% during the second quarter. IFP Advisors Inc now owns 614 shares of the company's stock worth $55,000 after acquiring an additional 488 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Stock Down 4.4%
Shares of HQY stock opened at $97.31 on Thursday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $110.26. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. The firm has a fifty day moving average of $96.52 and a 200-day moving average of $90.23. The company has a market capitalization of $8.05 billion, a price-to-earnings ratio of 35.13, a P/E/G ratio of 1.61 and a beta of 0.22.
HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.19 by $0.05. The business had revenue of $350.73 million for the quarter, compared to analysts' expectations of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The firm's quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities research analysts predict that HealthEquity, Inc. will post 3.94 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have issued reports on HQY shares. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research note on Saturday, October 10th. Raymond James Financial reaffirmed a "strong-buy" rating on shares of HealthEquity in a research report on Thursday, September 3rd. Telsey Advisory Group set a $111.00 price objective on HealthEquity in a report on Friday, August 28th. BTIG Research reiterated a "buy" rating and set a $115.00 price objective on shares of HealthEquity in a report on Friday, August 28th. Finally, Weiss Ratings lowered HealthEquity from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, HealthEquity presently has an average rating of "Moderate Buy" and a consensus price target of $113.53.
View Our Latest Analysis on HQY
Insider Activity
In other news, Director Adrian Dillon sold 7,632 shares of the business's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by corporate insiders.
HealthEquity Company Profile
(
Free Report)
HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.